vs
Side-by-side financial comparison of Federal Realty Investment Trust (FRT) and HUTCHMED (China) Ltd (HCM). Click either name above to swap in a different company.
Federal Realty Investment Trust is the larger business by last-quarter revenue ($336.0M vs $270.8M, roughly 1.2× HUTCHMED (China) Ltd). Federal Realty Investment Trust runs the higher net margin — 38.6% vs 0.7%, a 37.9% gap on every dollar of revenue. On growth, Federal Realty Investment Trust posted the faster year-over-year revenue change (8.7% vs -16.5%).
Federal Realty Investment Trust is a real estate investment trust that invests in shopping centers in the Northeastern United States, the Mid-Atlantic states, California, and South Florida.
HUTCHMED (China) LtdHCMEarnings & Financial Report
HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.
FRT vs HCM — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $336.0M | $270.8M |
| Net Profit | $129.7M | $2.0M |
| Gross Margin | — | 37.7% |
| Operating Margin | 53.8% | -13.2% |
| Net Margin | 38.6% | 0.7% |
| Revenue YoY | 8.7% | -16.5% |
| Net Profit YoY | 103.5% | -83.6% |
| EPS (diluted) | $1.49 | $0.00 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $336.0M | — | ||
| Q4 25 | $336.0M | $270.8M | ||
| Q3 25 | $322.3M | — | ||
| Q2 25 | $311.5M | $277.7M | ||
| Q1 25 | $309.2M | $324.5M | ||
| Q4 24 | $311.4M | — | ||
| Q3 24 | $303.6M | — | ||
| Q2 24 | $296.1M | $305.7M |
| Q1 26 | $129.7M | — | ||
| Q4 25 | $129.7M | $2.0M | ||
| Q3 25 | $61.6M | — | ||
| Q2 25 | $155.9M | $455.0M | ||
| Q1 25 | $63.8M | $11.9M | ||
| Q4 24 | $65.5M | — | ||
| Q3 24 | $61.0M | — | ||
| Q2 24 | $112.0M | $25.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | 37.7% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.1% | ||
| Q1 25 | — | 48.0% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 41.1% |
| Q1 26 | 53.8% | — | ||
| Q4 25 | 53.8% | -13.2% | ||
| Q3 25 | 34.3% | — | ||
| Q2 25 | 65.1% | -1.3% | ||
| Q1 25 | 35.0% | -5.0% | ||
| Q4 24 | 35.1% | — | ||
| Q3 24 | 34.9% | — | ||
| Q2 24 | 53.0% | -9.0% |
| Q1 26 | 38.6% | — | ||
| Q4 25 | 38.6% | 0.7% | ||
| Q3 25 | 19.1% | — | ||
| Q2 25 | 50.0% | 163.8% | ||
| Q1 25 | 20.6% | 3.7% | ||
| Q4 24 | 21.0% | — | ||
| Q3 24 | 20.1% | — | ||
| Q2 24 | 37.8% | 8.4% |
| Q1 26 | $1.49 | — | ||
| Q4 25 | $1.49 | $0.00 | ||
| Q3 25 | $0.69 | — | ||
| Q2 25 | $1.78 | $0.52 | ||
| Q1 25 | $0.72 | $0.01 | ||
| Q4 24 | $0.74 | — | ||
| Q3 24 | $0.70 | — | ||
| Q2 24 | $1.32 | $0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $107.4M | $1.4B |
| Total DebtLower is stronger | $5.0B | $93.2M |
| Stockholders' EquityBook value | $3.2B | $1.2B |
| Total Assets | $9.1B | $1.8B |
| Debt / EquityLower = less leverage | 1.53× | 0.08× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $107.4M | — | ||
| Q4 25 | $107.4M | $1.4B | ||
| Q3 25 | $111.3M | — | ||
| Q2 25 | $177.0M | $1.4B | ||
| Q1 25 | $109.2M | $836.1M | ||
| Q4 24 | $123.4M | — | ||
| Q3 24 | $97.0M | — | ||
| Q2 24 | $103.2M | $802.5M |
| Q1 26 | $5.0B | — | ||
| Q4 25 | $5.0B | $93.2M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $93.4M | ||
| Q1 25 | — | $82.8M | ||
| Q4 24 | $4.5B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $82.1M |
| Q1 26 | $3.2B | — | ||
| Q4 25 | $3.2B | $1.2B | ||
| Q3 25 | $3.2B | — | ||
| Q2 25 | $3.2B | $1.2B | ||
| Q1 25 | $3.2B | $759.9M | ||
| Q4 24 | $3.2B | — | ||
| Q3 24 | $3.1B | — | ||
| Q2 24 | $3.0B | $740.1M |
| Q1 26 | $9.1B | — | ||
| Q4 25 | $9.1B | $1.8B | ||
| Q3 25 | $8.9B | — | ||
| Q2 25 | $8.6B | $1.8B | ||
| Q1 25 | $8.6B | $1.3B | ||
| Q4 24 | $8.5B | — | ||
| Q3 24 | $8.5B | — | ||
| Q2 24 | $8.4B | $1.3B |
| Q1 26 | 1.53× | — | ||
| Q4 25 | 1.53× | 0.08× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.08× | ||
| Q1 25 | — | 0.11× | ||
| Q4 24 | 1.42× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.11× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $8.2M |
| Free Cash FlowOCF − Capex | — | $3.4M |
| FCF MarginFCF / Revenue | — | 1.2% |
| Capex IntensityCapex / Revenue | — | 1.8% |
| Cash ConversionOCF / Net Profit | — | 4.21× |
| TTM Free Cash FlowTrailing 4 quarters | — | $-96.2M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $622.4M | $8.2M | ||
| Q3 25 | $147.8M | — | ||
| Q2 25 | $150.7M | $-72.9M | ||
| Q1 25 | $179.0M | $40.3M | ||
| Q4 24 | $574.6M | — | ||
| Q3 24 | $144.1M | — | ||
| Q2 24 | $169.7M | $-39.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | $3.4M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $-82.2M | ||
| Q1 25 | — | $32.5M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $-49.9M |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.2% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -29.6% | ||
| Q1 25 | — | 10.0% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -16.3% |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.8% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 3.3% | ||
| Q1 25 | — | 2.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 3.3% |
| Q1 26 | — | — | ||
| Q4 25 | 4.80× | 4.21× | ||
| Q3 25 | 2.40× | — | ||
| Q2 25 | 0.97× | -0.16× | ||
| Q1 25 | 2.81× | 3.38× | ||
| Q4 24 | 8.77× | — | ||
| Q3 24 | 2.36× | — | ||
| Q2 24 | 1.52× | -1.54× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
